Global animal rights organization PETA has released comprehensive investigative footage detailing a sophisticated “laundering” scheme used to funnel wild-caught primates into the Western biomedical supply chain. The report reveals that thousands of long-tailed macaques (Macaca fascicularis) are being illegally trapped in Cambodian forests, transported to “breeding facilities,” and assigned falsified identification to circumvent international trade bans on endangered species.
The crisis reached a critical juncture in January 2026 when Charles River Laboratories, the world’s largest provider of contract research services, finalized a $510 million acquisition of major Cambodian primate suppliers, including K.F. (Cambodia) Ltd.
Analysts suggest this vertical integration is a strategic move to monopolize the supply chain and insulate the company from external scrutiny regarding animal origins. This acquisition occurred despite ongoing U.S. Department of Justice investigations into primate smuggling, which have already led to the indictment of high-ranking Cambodian wildlife officials for issuing fraudulent export permits.
Congresswoman Nicole Malliotakis (NY-11) has officially called upon U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to implement an immediate moratorium on the importation of non-human primates for laboratory experimentation. The formal request follows a high-level briefing between the Congresswoman, PETA’s Senior Science Advisor Dr. Lisa Jones-Engel, and honorary board member Edie Falco, during which evidence was presented regarding the systemic failure of the current primate trade to manage biosecurity and animal welfare.
Regulatory Failure and “Impossible” Biology
In a controversial ruling in March 2026, the CITES Standing Committee declined to enact a trade suspension on Cambodian macaques. This decision has been widely criticized by conservationists who point to “biologically impossible” breeding data submitted by Cambodian facilities. For instance, some farms reported monthly birth rates exceeding 50% of the total female population, a statistic that contradicts the known 165-day gestation period of the species.
Furthermore, the decision to allow trade to continue ignores the IUCN’s 2025 reassessment, which confirmed that long-tailed macaque populations have plummeted by 50–70% over the last three decades, primarily due to habitat loss and the “insatiable” demand from the research industry.
Biosecurity Risks and Policy Reversals
Beyond conservation ethics, the influx of wild-caught primates poses severe biosecurity risks. Wild macaques are frequent carriers of zoonotic pathogens, including tuberculosis and Herpes B, which can be fatal to humans.
Despite these risks, U.S. federal authorities in late 2025 reversed a previous seizure order, returning over 1,000 macaques to Charles River Laboratories for experimentation. This move ignored multiple offers from PETA and private donors to purchase the animals and relocate them to accredited sanctuaries.
The exposure of this “laundering” network is forcing a shift toward New Approach Methodologies (NAMs). International pressure is mounting for the U.S. and EU to implement a complete ban on Southeast Asian primate imports, which would mandate the adoption of organ-on-a-chip technologies and computer modeling—methods that PETA argues are more predictive of human biology than animal models.
